
VerTan Technologies is a holding nanotechnology company founded in 2024 that develops AI-driven therapeutics and consumer products based on its patented multi-noble metal nanoparticle platform, NobleFusion™. The company integrates nanotechnology with its proprietary AI platform, EurekaAI®, to optimize nanoparticle formulations for applications in medicine, cosmetics, agriculture, and veterinary science. Their technology enables targeted delivery of biologics and drugs, enhancing efficacy and reducing side effects, with promising applications in anti-cancer therapies, anti-aging cosmetics, antimicrobial products, and sustainable agriculture. VerTan's approach reduces R&D costs and time, supports early-stage revenue through cosmetic partnerships, and aims to expand into broader markets with innovative, biocompatible, and environmentally sustainable solutions. The company is led by experienced scientists and innovators with strong expertise in biotechnology, medicinal chemistry, and AI-driven product development.

VerTan Technologies is a holding nanotechnology company founded in 2024 that develops AI-driven therapeutics and consumer products based on its patented multi-noble metal nanoparticle platform, NobleFusion™. The company integrates nanotechnology with its proprietary AI platform, EurekaAI®, to optimize nanoparticle formulations for applications in medicine, cosmetics, agriculture, and veterinary science. Their technology enables targeted delivery of biologics and drugs, enhancing efficacy and reducing side effects, with promising applications in anti-cancer therapies, anti-aging cosmetics, antimicrobial products, and sustainable agriculture. VerTan's approach reduces R&D costs and time, supports early-stage revenue through cosmetic partnerships, and aims to expand into broader markets with innovative, biocompatible, and environmentally sustainable solutions. The company is led by experienced scientists and innovators with strong expertise in biotechnology, medicinal chemistry, and AI-driven product development.
Founded: 2024
Core tech: Patented multi-noble-metal nanoparticles (NobleFusion™) + AI platform (EurekaAI®)
Applications: Cosmetics, oncology, veterinary, agriculture
Funding signal: Seed round announced May 1, 2024
Improving delivery and efficacy of biologics/actives while reducing R&D time and costs across cosmetics, oncology, veterinary, and agriculture.
2024
Agriculture and Farming
Single Seed round announced; amount obfuscated in reporting.